$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Could This Potential Move Boost Eli Lilly's Prospects?
11:00am, Wednesday, 31'st Dec 2025
Eli Lilly is working on the acquisition of a France-based drugmaker. This could allow it to expand its footprint in the immunology market.
Eli Lilly and Company $LLY Shares Sold by First American Bank
05:46am, Wednesday, 31'st Dec 2025
First American Bank decreased its position in Eli Lilly and Company (NYSE: LLY) by 1.6% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Co
Copeland Capital Management LLC Sells 704 Shares of Eli Lilly and Company $LLY
05:46am, Wednesday, 31'st Dec 2025
Copeland Capital Management LLC lessened its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 3.3% during the undefined quarter, according to its most recent filing with the Securities and E
Fort Washington Investment Advisors Inc. OH Buys 14,301 Shares of Eli Lilly and Company $LLY
05:06am, Wednesday, 31'st Dec 2025
Fort Washington Investment Advisors Inc. OH increased its stake in shares of Eli Lilly and Company (NYSE: LLY) by 41.3% in the third quarter, according to its most recent Form 13F filing with the SEC.
Eli Lilly and Company $LLY Shares Sold by Farmers & Merchants Investments Inc.
05:06am, Wednesday, 31'st Dec 2025
Farmers and Merchants Investments Inc. trimmed its position in shares of Eli Lilly and Company (NYSE: LLY) by 3.2% in the third quarter, according to its most recent filing with the Securities and Exc
Eli Lilly and Novo Nordisk Shares Dip After Cut Obesity Drug Prices in China
11:57am, Tuesday, 30'th Dec 2025
Novo Nordisk (NVO) and Eli Lilly (LLY) saw their shares dip about 0.5% on Tuesday after the companies lowered prices for their obesity treatments in China.The D
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge
08:57am, Tuesday, 30'th Dec 2025
Biogen Inc. shares, despite retail investor pessimism, rose 15.1% in 2025. Besides the successful launch of Leqembi, I highlight Skyclarys, an Nrf2 activator for the treatment of Friedreich's ataxia,
Everpar Advisors LLC Buys 499 Shares of Eli Lilly and Company $LLY
05:00am, Tuesday, 30'th Dec 2025
Everpar Advisors LLC increased its stake in shares of Eli Lilly and Company (NYSE: LLY) by 22.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange
Kempner Capital Management Inc. Acquires New Position in Eli Lilly and Company $LLY
06:40am, Monday, 29'th Dec 2025
Kempner Capital Management Inc. bought a new position in shares of Eli Lilly and Company (NYSE: LLY) during the third quarter, according to the company in its most recent 13F filing with the Securitie
Mezzasalma Advisors LLC Sells 756 Shares of Eli Lilly and Company $LLY
06:40am, Monday, 29'th Dec 2025
Mezzasalma Advisors LLC lowered its stake in Eli Lilly and Company (NYSE: LLY) by 12.4% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exc
Greenwood Capital Associates LLC Has $10.05 Million Stock Position in Eli Lilly and Company $LLY
06:40am, Monday, 29'th Dec 2025
Greenwood Capital Associates LLC raised its stake in Eli Lilly and Company (NYSE: LLY) by 25.5% during the undefined quarter, according to the company in its most recent 13F filing with the Securities
Fulton Breakefield Broenniman LLC Has $30.21 Million Stock Position in Eli Lilly and Company $LLY
06:40am, Monday, 29'th Dec 2025
Fulton Breakefield Broenniman LLC lowered its stake in shares of Eli Lilly and Company (NYSE: LLY) by 2.2% during the third quarter, according to the company in its most recent filing with the Securit
NovaPoint Capital LLC Acquires 1,860 Shares of Eli Lilly and Company $LLY
05:46am, Monday, 29'th Dec 2025
NovaPoint Capital LLC boosted its holdings in Eli Lilly and Company (NYSE: LLY) by 55.9% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Ex
E. Ohman J or Asset Management AB Acquires 1,547 Shares of Eli Lilly and Company $LLY
04:29am, Monday, 29'th Dec 2025
E. Ohman J or Asset Management AB boosted its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 3.9% during the third quarter, according to the company in its most recent Form 13F filing with
Castle Rock Wealth Management LLC Boosts Stock Holdings in Eli Lilly and Company $LLY
04:29am, Monday, 29'th Dec 2025
Castle Rock Wealth Management LLC grew its stake in shares of Eli Lilly and Company (NYSE: LLY) by 32.0% in the undefined quarter, according to its most recent filing with the Securities and Exchange
Sign In
Buy LLY